Inhibition of orthotopic growth and metastasis of androgen‐sensitive human prostate tumors in mice by bioactive soybean components
- 19 September 2002
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 53 (2) , 143-153
- https://doi.org/10.1002/pros.10141
Abstract
BACKGROUND Systematic analysis of the influence of diet on the initiation and progression of prostate cancer is often difficult in human populations, for which dietary variables overlap a diversity of genetic backgrounds and social behaviors. Animal models that emulate human prostate cancer allow experimental analysis of the mechanisms of action of nutritional agents that show anti‐prostate cancer activity. METHODS We have used an orthotopic implant model to characterize the in vivo response of androgen‐sensitive LNCaP prostate tumors to three well‐characterized soy dietary supplements: isoflavone depleted soy protein, soy phytochemical concentrate (SPC), and genistin. RESULTS In male SCID mice orthotopically implanted with the androgen‐sensitive human prostate cell line LNCaP, dietary supplements of soy protein, genistin, and SPC reduced primary tumor weight by 42% (P = 0.07), 57% (P < 0.05) and 70% (P < 0.005), respectively. All three soy supplements significantly increased tumor apoptosis and decrease microvessel density, with no significant change in tumor proliferation. Each supplement produced a distinct serum androgen response, with genistin producing the greatest decrease in total serum testosterone and dihydrotestosterone (DHT) (P < 0.05) and the greatest increase in testosterone to DHT ratio (P < 0.05) and soy protein the greatest decrease in bioactive androgen (P < 0.05). Only SPC significantly inhibited metastases to lymph nodes and lungs, and only SPC produced a significant increase in tumor p53 expression. CONCLUSION Taken together, these data suggest that the anti‐prostate cancer activity of dietary soy protein, soy phytochemicals, and genistin use different molecular pathways. In addition, we have demonstrated that this animal model can be used in the design of dietary strategies for prostate cancer prevention and therapy. Prostate 53: 143–153, 2002.Keywords
This publication has 29 references indexed in Scilit:
- Liquid chromatographic–photodiode array mass spectrometric analysis of dietary phytoestrogens from human urine and bloodJournal of Chromatography B, 2002
- p21CIP1 Is Dispensable for the G2 Arrest Caused by Genistein in Human Melanoma CellsExperimental Cell Research, 2000
- p53‐independent Induction of p21 (WAF1/CIP1), Reduction of Cyclin B1 and G2/M Arrest by the Isoflavone Genistein in Human Prostate Carcinoma CellsJapanese Journal of Cancer Research, 2000
- Genistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cellsEuropean Journal Of Cancer, 1998
- Genistein Induces p21Cip1/WAF1Expression and Blocks the G1 to S Phase Transition in Mouse Fibroblast and Melanoma CellsBiochemical and Biophysical Research Communications, 1998
- Genistein‐induced upregulation of p21WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cellsNutrition and Cancer, 1998
- Soy intake and cancer risk: A review of thein vitroandin vivodataNutrition and Cancer, 1994
- Trends in diet-related cancers in Japan: a conundrum?The Lancet, 1993
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Production, clearance, and metabolism of testosterone in men with prostatic cancerThe Prostate, 1986